# | Title | Journal | Year | Citations |
---|
1 | Gastric cancer: epidemiology, prevention, classification, and treatment | Cancer Management and Research | 2018 | 745 |
2 | <p>Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades</p> | Cancer Management and Research | 2019 | 359 |
3 | <p>The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances</p> | Cancer Management and Research | 2019 | 238 |
4 | Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature | Cancer Management and Research | 2014 | 222 |
5 | MALAT1: a potential biomarker in cancer | Cancer Management and Research | 2018 | 197 |
6 | IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis | Cancer Management and Research | 2018 | 186 |
7 | Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution | Cancer Management and Research | 2012 | 181 |
8 | Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer | Cancer Management and Research | 0 | 172 |
9 | Interstitial fluid flow in cancer: implications for disease progression and treatment | Cancer Management and Research | 2014 | 169 |
10 | Head and neck cancer: improving outcomes with a multidisciplinary approach | Cancer Management and Research | 2017 | 150 |
11 | Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods | Cancer Management and Research | 2014 | 149 |
12 | Presentation and management of docetaxel-related adverse effects in patients with breast cancer | Cancer Management and Research | 2014 | 147 |
13 | Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives | Cancer Management and Research | 2014 | 144 |
14 | Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis | Cancer Management and Research | 2017 | 128 |
15 | Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study | Cancer Management and Research | 2018 | 124 |
16 | Cancer chemotherapy: targeting folic acid synthesis | Cancer Management and Research | 2010 | 122 |
17 | Autophagy as a target for cancer therapy: new developments | Cancer Management and Research | 2012 | 118 |
18 | The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective | Cancer Management and Research | 2013 | 117 |
19 | The impact of mindfulness-based interventions on symptom burden, positive psychological outcomes, and biomarkers in cancer patients | Cancer Management and Research | 2015 | 117 |
20 | Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies | Cancer Management and Research | 2011 | 116 |
21 | <p>Cancer Cachexia: Definition, Staging, and Emerging Treatments</p> | Cancer Management and Research | 2020 | 115 |
22 | <p>The Anti-Cancer Mechanisms of Berberine: A Review</p> | Cancer Management and Research | 2020 | 114 |
23 | The clinical promise of immunotherapy in triple-negative breast cancer | Cancer Management and Research | 2018 | 113 |
24 | Fertility preservation during cancer treatment: clinical guidelines | Cancer Management and Research | 2014 | 109 |
25 | Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies | Cancer Management and Research | 2018 | 109 |
26 | <p>miR-600 inhibits lung cancer via downregulating the expression of METTL3</p> | Cancer Management and Research | 2019 | 107 |
27 | Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease | Cancer Management and Research | 2013 | 101 |
28 | Radiation-induced skin reactions: mechanism and treatment | Cancer Management and Research | 2019 | 101 |
29 | Prognosis of patients with neuroendocrine tumor: a SEER database analysis | Cancer Management and Research | 2018 | 100 |
30 | Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer | Cancer Management and Research | 2018 | 100 |
31 | Targeting autophagy in cancer management – strategies and developments | Cancer Management and Research | 2015 | 96 |
32 | <p>M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer</p> | Cancer Management and Research | 2019 | 96 |
33 | The claudin family of proteins in human malignancy: a clinical perspective | Cancer Management and Research | 2013 | 94 |
34 | Nedaplatin: a cisplatin derivative in cancer chemotherapy | Cancer Management and Research | 2013 | 94 |
35 | A review of soft-tissue sarcomas: translation of biological advances into treatment measures | Cancer Management and Research | 2018 | 94 |
36 | Carotid blowout syndrome: modern trends in management | Cancer Management and Research | 2018 | 93 |
37 | MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells | Cancer Management and Research | 2018 | 93 |
38 | Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy? | Cancer Management and Research | 2018 | 92 |
39 | <p>Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets</p> | Cancer Management and Research | 2019 | 91 |
40 | Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression | Cancer Management and Research | 2018 | 85 |
41 | <p>CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management</p> | Cancer Management and Research | 2019 | 85 |
42 | Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies | Cancer Management and Research | 2013 | 84 |
43 | Cancer therapy and cardiovascular risk: focus on bevacizumab | Cancer Management and Research | 2015 | 84 |
44 | CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer | Cancer Management and Research | 2018 | 83 |
45 | <p>A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of <em>BRCA</em>-mutated breast cancer</p> | Cancer Management and Research | 2019 | 83 |
46 | <p>Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer</p> | Cancer Management and Research | 2019 | 82 |
47 | Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials | Cancer Management and Research | 2017 | 81 |
48 | Bone metastasis pattern in initial metastatic breast cancer: a population-based study | Cancer Management and Research | 2018 | 81 |
49 | Multiple neoplasms, single primaries, and patient survival | Cancer Management and Research | 2014 | 80 |
50 | Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways | Cancer Management and Research | 2019 | 80 |